Global Prescription Weight Loss Pills Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Prescription Weight Loss Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Weight Loss Pills.
The Prescription Weight Loss Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prescription Weight Loss Pills market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Weight Loss Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription Weight Loss Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Prescription Weight Loss Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prescription Weight Loss Pills market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Weight Loss Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Currax Pharmaceuticals (Contrave)
- VIVUS (Qsymia)
- Novo Nordisk A/S
- Rhythm Pharmaceuticals (Imcivree)
- Eli Lilly and Company (TRICARE)
- CHEPLAPHARM (Xenical)
- Pfizer
- Teva Pharmaceutical (Actavis)
- Haleon Group (alli)
- Sanofi (Adlyxin)
- AstraZeneca (BYDUREON BCise)
- Oral Tablets
- Oral Capsules
- Injections
- Hospital
- Pharmacy
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription Weight Loss Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 PRESCRIPTION WEIGHT LOSS PILLS MARKET OVERVIEW
1.1 Product Overview and Scope of Prescription Weight Loss Pills
1.2 Prescription Weight Loss Pills Segment by Type
1.2.1 Global Prescription Weight Loss Pills Market Value Comparison by Type (2023-2029)
1.2.2 Oral Tablets
1.2.3 Oral Capsules
1.2.4 Injections
1.3 Prescription Weight Loss Pills Segment by Application
1.3.1 Global Prescription Weight Loss Pills Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Prescription Weight Loss Pills Market Size Estimates and Forecasts
1.4.1 Global Prescription Weight Loss Pills Revenue 2018-2029
1.4.2 Global Prescription Weight Loss Pills Sales 2018-2029
1.4.3 Global Prescription Weight Loss Pills Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PRESCRIPTION WEIGHT LOSS PILLS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2018-2023)
2.2 Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Prescription Weight Loss Pills Average Price by Manufacturers (2018-2023)
2.4 Global Prescription Weight Loss Pills Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Weight Loss Pills, Product Type & Application
2.7 Prescription Weight Loss Pills Market Competitive Situation and Trends
2.7.1 Prescription Weight Loss Pills Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prescription Weight Loss Pills Players Market Share by Revenue
2.7.3 Global Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PRESCRIPTION WEIGHT LOSS PILLS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Prescription Weight Loss Pills Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Prescription Weight Loss Pills Global Prescription Weight Loss Pills Sales by Region: 2018-2029
3.2.1 Global Prescription Weight Loss Pills Sales by Region: 2018-2023
3.2.2 Global Prescription Weight Loss Pills Sales by Region: 2024-2029
3.3 Global Prescription Weight Loss Pills Global Prescription Weight Loss Pills Revenue by Region: 2018-2029
3.3.1 Global Prescription Weight Loss Pills Revenue by Region: 2018-2023
3.3.2 Global Prescription Weight Loss Pills Revenue by Region: 2024-2029
3.4 North America Prescription Weight Loss Pills Market Facts & Figures by Country
3.4.1 North America Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Prescription Weight Loss Pills Sales by Country (2018-2029)
3.4.3 North America Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prescription Weight Loss Pills Market Facts & Figures by Country
3.5.1 Europe Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Prescription Weight Loss Pills Sales by Country (2018-2029)
3.5.3 Europe Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Weight Loss Pills Market Facts & Figures by Country
3.6.1 Asia Pacific Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Prescription Weight Loss Pills Sales by Country (2018-2029)
3.6.3 Asia Pacific Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prescription Weight Loss Pills Market Facts & Figures by Country
3.7.1 Latin America Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Prescription Weight Loss Pills Sales by Country (2018-2029)
3.7.3 Latin America Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Prescription Weight Loss Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Prescription Weight Loss Pills Sales by Country (2018-2029)
3.8.3 Middle East and Africa Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Prescription Weight Loss Pills Sales by Type (2018-2029)
4.1.1 Global Prescription Weight Loss Pills Sales by Type (2018-2023)
4.1.2 Global Prescription Weight Loss Pills Sales by Type (2024-2029)
4.1.3 Global Prescription Weight Loss Pills Sales Market Share by Type (2018-2029)
4.2 Global Prescription Weight Loss Pills Revenue by Type (2018-2029)
4.2.1 Global Prescription Weight Loss Pills Revenue by Type (2018-2023)
4.2.2 Global Prescription Weight Loss Pills Revenue by Type (2024-2029)
4.2.3 Global Prescription Weight Loss Pills Revenue Market Share by Type (2018-2029)
4.3 Global Prescription Weight Loss Pills Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Prescription Weight Loss Pills Sales by Application (2018-2029)
5.1.1 Global Prescription Weight Loss Pills Sales by Application (2018-2023)
5.1.2 Global Prescription Weight Loss Pills Sales by Application (2024-2029)
5.1.3 Global Prescription Weight Loss Pills Sales Market Share by Application (2018-2029)
5.2 Global Prescription Weight Loss Pills Revenue by Application (2018-2029)
5.2.1 Global Prescription Weight Loss Pills Revenue by Application (2018-2023)
5.2.2 Global Prescription Weight Loss Pills Revenue by Application (2024-2029)
5.2.3 Global Prescription Weight Loss Pills Revenue Market Share by Application (2018-2029)
5.3 Global Prescription Weight Loss Pills Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Currax Pharmaceuticals (Contrave)
6.1.1 Currax Pharmaceuticals (Contrave) Corporation Information
6.1.2 Currax Pharmaceuticals (Contrave) Description and Business Overview
6.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
6.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
6.2 VIVUS (Qsymia)
6.2.1 VIVUS (Qsymia) Corporation Information
6.2.2 VIVUS (Qsymia) Description and Business Overview
6.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
6.2.5 VIVUS (Qsymia) Recent Developments/Updates
6.3 Novo Nordisk A/S
6.3.1 Novo Nordisk A/S Corporation Information
6.3.2 Novo Nordisk A/S Description and Business Overview
6.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
6.3.5 Novo Nordisk A/S Recent Developments/Updates
6.4 Rhythm Pharmaceuticals (Imcivree)
6.4.1 Rhythm Pharmaceuticals (Imcivree) Corporation Information
6.4.2 Rhythm Pharmaceuticals (Imcivree) Description and Business Overview
6.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
6.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
6.5 Eli Lilly and Company (TRICARE)
6.5.1 Eli Lilly and Company (TRICARE) Corporation Information
6.5.2 Eli Lilly and Company (TRICARE) Description and Business Overview
6.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
6.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
6.6 CHEPLAPHARM (Xenical)
6.6.1 CHEPLAPHARM (Xenical) Corporation Information
6.6.2 CHEPLAPHARM (Xenical) Description and Business Overview
6.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
6.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Prescription Weight Loss Pills Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical (Actavis)
6.8.1 Teva Pharmaceutical (Actavis) Corporation Information
6.8.2 Teva Pharmaceutical (Actavis) Description and Business Overview
6.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
6.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
6.9 Haleon Group (alli)
6.9.1 Haleon Group (alli) Corporation Information
6.9.2 Haleon Group (alli) Description and Business Overview
6.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
6.9.5 Haleon Group (alli) Recent Developments/Updates
6.10 Sanofi (Adlyxin)
6.10.1 Sanofi (Adlyxin) Corporation Information
6.10.2 Sanofi (Adlyxin) Description and Business Overview
6.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
6.10.5 Sanofi (Adlyxin) Recent Developments/Updates
6.11 AstraZeneca (BYDUREON BCise)
6.11.1 AstraZeneca (BYDUREON BCise) Corporation Information
6.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Description and Business Overview
6.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
6.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Prescription Weight Loss Pills Industry Chain Analysis
7.2 Prescription Weight Loss Pills Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Weight Loss Pills Production Mode & Process
7.4 Prescription Weight Loss Pills Sales and Marketing
7.4.1 Prescription Weight Loss Pills Sales Channels
7.4.2 Prescription Weight Loss Pills Distributors
7.5 Prescription Weight Loss Pills Customers
8 PRESCRIPTION WEIGHT LOSS PILLS MARKET DYNAMICS
8.1 Prescription Weight Loss Pills Industry Trends
8.2 Prescription Weight Loss Pills Market Drivers
8.3 Prescription Weight Loss Pills Market Challenges
8.4 Prescription Weight Loss Pills Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Prescription Weight Loss Pills
1.2 Prescription Weight Loss Pills Segment by Type
1.2.1 Global Prescription Weight Loss Pills Market Value Comparison by Type (2023-2029)
1.2.2 Oral Tablets
1.2.3 Oral Capsules
1.2.4 Injections
1.3 Prescription Weight Loss Pills Segment by Application
1.3.1 Global Prescription Weight Loss Pills Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Prescription Weight Loss Pills Market Size Estimates and Forecasts
1.4.1 Global Prescription Weight Loss Pills Revenue 2018-2029
1.4.2 Global Prescription Weight Loss Pills Sales 2018-2029
1.4.3 Global Prescription Weight Loss Pills Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PRESCRIPTION WEIGHT LOSS PILLS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2018-2023)
2.2 Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Prescription Weight Loss Pills Average Price by Manufacturers (2018-2023)
2.4 Global Prescription Weight Loss Pills Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Weight Loss Pills, Product Type & Application
2.7 Prescription Weight Loss Pills Market Competitive Situation and Trends
2.7.1 Prescription Weight Loss Pills Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prescription Weight Loss Pills Players Market Share by Revenue
2.7.3 Global Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PRESCRIPTION WEIGHT LOSS PILLS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Prescription Weight Loss Pills Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Prescription Weight Loss Pills Global Prescription Weight Loss Pills Sales by Region: 2018-2029
3.2.1 Global Prescription Weight Loss Pills Sales by Region: 2018-2023
3.2.2 Global Prescription Weight Loss Pills Sales by Region: 2024-2029
3.3 Global Prescription Weight Loss Pills Global Prescription Weight Loss Pills Revenue by Region: 2018-2029
3.3.1 Global Prescription Weight Loss Pills Revenue by Region: 2018-2023
3.3.2 Global Prescription Weight Loss Pills Revenue by Region: 2024-2029
3.4 North America Prescription Weight Loss Pills Market Facts & Figures by Country
3.4.1 North America Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Prescription Weight Loss Pills Sales by Country (2018-2029)
3.4.3 North America Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prescription Weight Loss Pills Market Facts & Figures by Country
3.5.1 Europe Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Prescription Weight Loss Pills Sales by Country (2018-2029)
3.5.3 Europe Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Weight Loss Pills Market Facts & Figures by Country
3.6.1 Asia Pacific Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Prescription Weight Loss Pills Sales by Country (2018-2029)
3.6.3 Asia Pacific Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prescription Weight Loss Pills Market Facts & Figures by Country
3.7.1 Latin America Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Prescription Weight Loss Pills Sales by Country (2018-2029)
3.7.3 Latin America Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Prescription Weight Loss Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Weight Loss Pills Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Prescription Weight Loss Pills Sales by Country (2018-2029)
3.8.3 Middle East and Africa Prescription Weight Loss Pills Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Prescription Weight Loss Pills Sales by Type (2018-2029)
4.1.1 Global Prescription Weight Loss Pills Sales by Type (2018-2023)
4.1.2 Global Prescription Weight Loss Pills Sales by Type (2024-2029)
4.1.3 Global Prescription Weight Loss Pills Sales Market Share by Type (2018-2029)
4.2 Global Prescription Weight Loss Pills Revenue by Type (2018-2029)
4.2.1 Global Prescription Weight Loss Pills Revenue by Type (2018-2023)
4.2.2 Global Prescription Weight Loss Pills Revenue by Type (2024-2029)
4.2.3 Global Prescription Weight Loss Pills Revenue Market Share by Type (2018-2029)
4.3 Global Prescription Weight Loss Pills Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Prescription Weight Loss Pills Sales by Application (2018-2029)
5.1.1 Global Prescription Weight Loss Pills Sales by Application (2018-2023)
5.1.2 Global Prescription Weight Loss Pills Sales by Application (2024-2029)
5.1.3 Global Prescription Weight Loss Pills Sales Market Share by Application (2018-2029)
5.2 Global Prescription Weight Loss Pills Revenue by Application (2018-2029)
5.2.1 Global Prescription Weight Loss Pills Revenue by Application (2018-2023)
5.2.2 Global Prescription Weight Loss Pills Revenue by Application (2024-2029)
5.2.3 Global Prescription Weight Loss Pills Revenue Market Share by Application (2018-2029)
5.3 Global Prescription Weight Loss Pills Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Currax Pharmaceuticals (Contrave)
6.1.1 Currax Pharmaceuticals (Contrave) Corporation Information
6.1.2 Currax Pharmaceuticals (Contrave) Description and Business Overview
6.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
6.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
6.2 VIVUS (Qsymia)
6.2.1 VIVUS (Qsymia) Corporation Information
6.2.2 VIVUS (Qsymia) Description and Business Overview
6.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
6.2.5 VIVUS (Qsymia) Recent Developments/Updates
6.3 Novo Nordisk A/S
6.3.1 Novo Nordisk A/S Corporation Information
6.3.2 Novo Nordisk A/S Description and Business Overview
6.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
6.3.5 Novo Nordisk A/S Recent Developments/Updates
6.4 Rhythm Pharmaceuticals (Imcivree)
6.4.1 Rhythm Pharmaceuticals (Imcivree) Corporation Information
6.4.2 Rhythm Pharmaceuticals (Imcivree) Description and Business Overview
6.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
6.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
6.5 Eli Lilly and Company (TRICARE)
6.5.1 Eli Lilly and Company (TRICARE) Corporation Information
6.5.2 Eli Lilly and Company (TRICARE) Description and Business Overview
6.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
6.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
6.6 CHEPLAPHARM (Xenical)
6.6.1 CHEPLAPHARM (Xenical) Corporation Information
6.6.2 CHEPLAPHARM (Xenical) Description and Business Overview
6.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
6.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Prescription Weight Loss Pills Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical (Actavis)
6.8.1 Teva Pharmaceutical (Actavis) Corporation Information
6.8.2 Teva Pharmaceutical (Actavis) Description and Business Overview
6.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
6.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
6.9 Haleon Group (alli)
6.9.1 Haleon Group (alli) Corporation Information
6.9.2 Haleon Group (alli) Description and Business Overview
6.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
6.9.5 Haleon Group (alli) Recent Developments/Updates
6.10 Sanofi (Adlyxin)
6.10.1 Sanofi (Adlyxin) Corporation Information
6.10.2 Sanofi (Adlyxin) Description and Business Overview
6.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
6.10.5 Sanofi (Adlyxin) Recent Developments/Updates
6.11 AstraZeneca (BYDUREON BCise)
6.11.1 AstraZeneca (BYDUREON BCise) Corporation Information
6.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Description and Business Overview
6.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2018-2023)
6.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
6.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Prescription Weight Loss Pills Industry Chain Analysis
7.2 Prescription Weight Loss Pills Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Weight Loss Pills Production Mode & Process
7.4 Prescription Weight Loss Pills Sales and Marketing
7.4.1 Prescription Weight Loss Pills Sales Channels
7.4.2 Prescription Weight Loss Pills Distributors
7.5 Prescription Weight Loss Pills Customers
8 PRESCRIPTION WEIGHT LOSS PILLS MARKET DYNAMICS
8.1 Prescription Weight Loss Pills Industry Trends
8.2 Prescription Weight Loss Pills Market Drivers
8.3 Prescription Weight Loss Pills Market Challenges
8.4 Prescription Weight Loss Pills Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Prescription Weight Loss Pills Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Prescription Weight Loss Pills Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Prescription Weight Loss Pills Market Competitive Situation by Manufacturers in 2022
Table 4. Global Prescription Weight Loss Pills Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Prescription Weight Loss Pills Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Prescription Weight Loss Pills Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Prescription Weight Loss Pills Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Prescription Weight Loss Pills, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prescription Weight Loss Pills, Product Type & Application
Table 12. Global Key Manufacturers of Prescription Weight Loss Pills, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prescription Weight Loss Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Weight Loss Pills as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prescription Weight Loss Pills Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Prescription Weight Loss Pills Sales by Region (2018-2023) & (K Units)
Table 18. Global Prescription Weight Loss Pills Sales Market Share by Region (2018-2023)
Table 19. Global Prescription Weight Loss Pills Sales by Region (2024-2029) & (K Units)
Table 20. Global Prescription Weight Loss Pills Sales Market Share by Region (2024-2029)
Table 21. Global Prescription Weight Loss Pills Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Prescription Weight Loss Pills Revenue Market Share by Region (2018-2023)
Table 23. Global Prescription Weight Loss Pills Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Prescription Weight Loss Pills Revenue Market Share by Region (2024-2029)
Table 25. North America Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 27. North America Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 28. North America Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 32. Europe Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 33. Europe Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Prescription Weight Loss Pills Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Prescription Weight Loss Pills Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Prescription Weight Loss Pills Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Prescription Weight Loss Pills Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Prescription Weight Loss Pills Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Prescription Weight Loss Pills Sales (K Units) by Type (2018-2023)
Table 51. Global Prescription Weight Loss Pills Sales (K Units) by Type (2024-2029)
Table 52. Global Prescription Weight Loss Pills Sales Market Share by Type (2018-2023)
Table 53. Global Prescription Weight Loss Pills Sales Market Share by Type (2024-2029)
Table 54. Global Prescription Weight Loss Pills Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Prescription Weight Loss Pills Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Prescription Weight Loss Pills Revenue Market Share by Type (2018-2023)
Table 57. Global Prescription Weight Loss Pills Revenue Market Share by Type (2024-2029)
Table 58. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2018-2023)
Table 59. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2024-2029)
Table 60. Global Prescription Weight Loss Pills Sales (K Units) by Application (2018-2023)
Table 61. Global Prescription Weight Loss Pills Sales (K Units) by Application (2024-2029)
Table 62. Global Prescription Weight Loss Pills Sales Market Share by Application (2018-2023)
Table 63. Global Prescription Weight Loss Pills Sales Market Share by Application (2024-2029)
Table 64. Global Prescription Weight Loss Pills Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Prescription Weight Loss Pills Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Prescription Weight Loss Pills Revenue Market Share by Application (2018-2023)
Table 67. Global Prescription Weight Loss Pills Revenue Market Share by Application (2024-2029)
Table 68. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2018-2023)
Table 69. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2024-2029)
Table 70. Currax Pharmaceuticals (Contrave) Corporation Information
Table 71. Currax Pharmaceuticals (Contrave) Description and Business Overview
Table 72. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product
Table 74. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
Table 75. VIVUS (Qsymia) Corporation Information
Table 76. VIVUS (Qsymia) Description and Business Overview
Table 77. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. VIVUS (Qsymia) Prescription Weight Loss Pills Product
Table 79. VIVUS (Qsymia) Recent Developments/Updates
Table 80. Novo Nordisk A/S Corporation Information
Table 81. Novo Nordisk A/S Description and Business Overview
Table 82. Novo Nordisk A/S Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novo Nordisk A/S Prescription Weight Loss Pills Product
Table 84. Novo Nordisk A/S Recent Developments/Updates
Table 85. Rhythm Pharmaceuticals (Imcivree) Corporation Information
Table 86. Rhythm Pharmaceuticals (Imcivree) Description and Business Overview
Table 87. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product
Table 89. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
Table 90. Eli Lilly and Company (TRICARE) Corporation Information
Table 91. Eli Lilly and Company (TRICARE) Description and Business Overview
Table 92. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product
Table 94. Eli Lilly and Company (TRICARE) Recent Developments/Updates
Table 95. CHEPLAPHARM (Xenical) Corporation Information
Table 96. CHEPLAPHARM (Xenical) Description and Business Overview
Table 97. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product
Table 99. CHEPLAPHARM (Xenical) Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Pfizer Prescription Weight Loss Pills Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Teva Pharmaceutical (Actavis) Corporation Information
Table 106. Teva Pharmaceutical (Actavis) Description and Business Overview
Table 107. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product
Table 109. Teva Pharmaceutical (Actavis) Recent Developments/Updates
Table 110. Haleon Group (alli) Corporation Information
Table 111. Haleon Group (alli) Description and Business Overview
Table 112. Haleon Group (alli) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Haleon Group (alli) Prescription Weight Loss Pills Product
Table 114. Haleon Group (alli) Recent Developments/Updates
Table 115. Sanofi (Adlyxin) Corporation Information
Table 116. Sanofi (Adlyxin) Description and Business Overview
Table 117. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi (Adlyxin) Prescription Weight Loss Pills Product
Table 119. Sanofi (Adlyxin) Recent Developments/Updates
Table 120. AstraZeneca (BYDUREON BCise) Corporation Information
Table 121. AstraZeneca (BYDUREON BCise) Description and Business Overview
Table 122. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product
Table 124. AstraZeneca (BYDUREON BCise) Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Prescription Weight Loss Pills Distributors List
Table 128. Prescription Weight Loss Pills Customers List
Table 129. Prescription Weight Loss Pills Market Trends
Table 130. Prescription Weight Loss Pills Market Drivers
Table 131. Prescription Weight Loss Pills Market Challenges
Table 132. Prescription Weight Loss Pills Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 1. Global Prescription Weight Loss Pills Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Prescription Weight Loss Pills Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Prescription Weight Loss Pills Market Competitive Situation by Manufacturers in 2022
Table 4. Global Prescription Weight Loss Pills Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Prescription Weight Loss Pills Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Prescription Weight Loss Pills Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Prescription Weight Loss Pills Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Prescription Weight Loss Pills, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prescription Weight Loss Pills, Product Type & Application
Table 12. Global Key Manufacturers of Prescription Weight Loss Pills, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prescription Weight Loss Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Weight Loss Pills as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prescription Weight Loss Pills Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Prescription Weight Loss Pills Sales by Region (2018-2023) & (K Units)
Table 18. Global Prescription Weight Loss Pills Sales Market Share by Region (2018-2023)
Table 19. Global Prescription Weight Loss Pills Sales by Region (2024-2029) & (K Units)
Table 20. Global Prescription Weight Loss Pills Sales Market Share by Region (2024-2029)
Table 21. Global Prescription Weight Loss Pills Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Prescription Weight Loss Pills Revenue Market Share by Region (2018-2023)
Table 23. Global Prescription Weight Loss Pills Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Prescription Weight Loss Pills Revenue Market Share by Region (2024-2029)
Table 25. North America Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 27. North America Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 28. North America Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 32. Europe Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 33. Europe Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Prescription Weight Loss Pills Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Prescription Weight Loss Pills Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Prescription Weight Loss Pills Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Prescription Weight Loss Pills Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Prescription Weight Loss Pills Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prescription Weight Loss Pills Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Prescription Weight Loss Pills Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Prescription Weight Loss Pills Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Prescription Weight Loss Pills Sales (K Units) by Type (2018-2023)
Table 51. Global Prescription Weight Loss Pills Sales (K Units) by Type (2024-2029)
Table 52. Global Prescription Weight Loss Pills Sales Market Share by Type (2018-2023)
Table 53. Global Prescription Weight Loss Pills Sales Market Share by Type (2024-2029)
Table 54. Global Prescription Weight Loss Pills Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Prescription Weight Loss Pills Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Prescription Weight Loss Pills Revenue Market Share by Type (2018-2023)
Table 57. Global Prescription Weight Loss Pills Revenue Market Share by Type (2024-2029)
Table 58. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2018-2023)
Table 59. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2024-2029)
Table 60. Global Prescription Weight Loss Pills Sales (K Units) by Application (2018-2023)
Table 61. Global Prescription Weight Loss Pills Sales (K Units) by Application (2024-2029)
Table 62. Global Prescription Weight Loss Pills Sales Market Share by Application (2018-2023)
Table 63. Global Prescription Weight Loss Pills Sales Market Share by Application (2024-2029)
Table 64. Global Prescription Weight Loss Pills Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Prescription Weight Loss Pills Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Prescription Weight Loss Pills Revenue Market Share by Application (2018-2023)
Table 67. Global Prescription Weight Loss Pills Revenue Market Share by Application (2024-2029)
Table 68. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2018-2023)
Table 69. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2024-2029)
Table 70. Currax Pharmaceuticals (Contrave) Corporation Information
Table 71. Currax Pharmaceuticals (Contrave) Description and Business Overview
Table 72. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product
Table 74. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
Table 75. VIVUS (Qsymia) Corporation Information
Table 76. VIVUS (Qsymia) Description and Business Overview
Table 77. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. VIVUS (Qsymia) Prescription Weight Loss Pills Product
Table 79. VIVUS (Qsymia) Recent Developments/Updates
Table 80. Novo Nordisk A/S Corporation Information
Table 81. Novo Nordisk A/S Description and Business Overview
Table 82. Novo Nordisk A/S Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novo Nordisk A/S Prescription Weight Loss Pills Product
Table 84. Novo Nordisk A/S Recent Developments/Updates
Table 85. Rhythm Pharmaceuticals (Imcivree) Corporation Information
Table 86. Rhythm Pharmaceuticals (Imcivree) Description and Business Overview
Table 87. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product
Table 89. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
Table 90. Eli Lilly and Company (TRICARE) Corporation Information
Table 91. Eli Lilly and Company (TRICARE) Description and Business Overview
Table 92. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product
Table 94. Eli Lilly and Company (TRICARE) Recent Developments/Updates
Table 95. CHEPLAPHARM (Xenical) Corporation Information
Table 96. CHEPLAPHARM (Xenical) Description and Business Overview
Table 97. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product
Table 99. CHEPLAPHARM (Xenical) Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Pfizer Prescription Weight Loss Pills Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Teva Pharmaceutical (Actavis) Corporation Information
Table 106. Teva Pharmaceutical (Actavis) Description and Business Overview
Table 107. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product
Table 109. Teva Pharmaceutical (Actavis) Recent Developments/Updates
Table 110. Haleon Group (alli) Corporation Information
Table 111. Haleon Group (alli) Description and Business Overview
Table 112. Haleon Group (alli) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Haleon Group (alli) Prescription Weight Loss Pills Product
Table 114. Haleon Group (alli) Recent Developments/Updates
Table 115. Sanofi (Adlyxin) Corporation Information
Table 116. Sanofi (Adlyxin) Description and Business Overview
Table 117. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi (Adlyxin) Prescription Weight Loss Pills Product
Table 119. Sanofi (Adlyxin) Recent Developments/Updates
Table 120. AstraZeneca (BYDUREON BCise) Corporation Information
Table 121. AstraZeneca (BYDUREON BCise) Description and Business Overview
Table 122. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product
Table 124. AstraZeneca (BYDUREON BCise) Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Prescription Weight Loss Pills Distributors List
Table 128. Prescription Weight Loss Pills Customers List
Table 129. Prescription Weight Loss Pills Market Trends
Table 130. Prescription Weight Loss Pills Market Drivers
Table 131. Prescription Weight Loss Pills Market Challenges
Table 132. Prescription Weight Loss Pills Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Prescription Weight Loss Pills
Figure 2. Global Prescription Weight Loss Pills Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Prescription Weight Loss Pills Market Share by Type in 2022 & 2029
Figure 4. Oral Tablets Product Picture
Figure 5. Oral Capsules Product Picture
Figure 6. Injections Product Picture
Figure 7. Global Prescription Weight Loss Pills Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Prescription Weight Loss Pills Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Global Prescription Weight Loss Pills Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Prescription Weight Loss Pills Market Size (2018-2029) & (US$ Million)
Figure 13. Global Prescription Weight Loss Pills Sales (2018-2029) & (K Units)
Figure 14. Global Prescription Weight Loss Pills Average Price (US$/Unit) & (2018-2029)
Figure 15. Prescription Weight Loss Pills Report Years Considered
Figure 16. Prescription Weight Loss Pills Sales Share by Manufacturers in 2022
Figure 17. Global Prescription Weight Loss Pills Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Prescription Weight Loss Pills Players: Market Share by Revenue in 2022
Figure 19. Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Prescription Weight Loss Pills Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 22. North America Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 23. United States Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 26. Europe Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 27. Germany Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Prescription Weight Loss Pills Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Prescription Weight Loss Pills Revenue Market Share by Region (2018-2029)
Figure 34. China Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 42. Latin America Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Prescription Weight Loss Pills by Type (2018-2029)
Figure 53. Global Revenue Market Share of Prescription Weight Loss Pills by Type (2018-2029)
Figure 54. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Prescription Weight Loss Pills by Application (2018-2029)
Figure 56. Global Revenue Market Share of Prescription Weight Loss Pills by Application (2018-2029)
Figure 57. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2018-2029)
Figure 58. Prescription Weight Loss Pills Value Chain
Figure 59. Prescription Weight Loss Pills Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Prescription Weight Loss Pills
Figure 2. Global Prescription Weight Loss Pills Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Prescription Weight Loss Pills Market Share by Type in 2022 & 2029
Figure 4. Oral Tablets Product Picture
Figure 5. Oral Capsules Product Picture
Figure 6. Injections Product Picture
Figure 7. Global Prescription Weight Loss Pills Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Prescription Weight Loss Pills Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Global Prescription Weight Loss Pills Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Prescription Weight Loss Pills Market Size (2018-2029) & (US$ Million)
Figure 13. Global Prescription Weight Loss Pills Sales (2018-2029) & (K Units)
Figure 14. Global Prescription Weight Loss Pills Average Price (US$/Unit) & (2018-2029)
Figure 15. Prescription Weight Loss Pills Report Years Considered
Figure 16. Prescription Weight Loss Pills Sales Share by Manufacturers in 2022
Figure 17. Global Prescription Weight Loss Pills Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Prescription Weight Loss Pills Players: Market Share by Revenue in 2022
Figure 19. Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Prescription Weight Loss Pills Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 22. North America Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 23. United States Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 26. Europe Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 27. Germany Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Prescription Weight Loss Pills Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Prescription Weight Loss Pills Revenue Market Share by Region (2018-2029)
Figure 34. China Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 42. Latin America Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Prescription Weight Loss Pills Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Prescription Weight Loss Pills Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Prescription Weight Loss Pills by Type (2018-2029)
Figure 53. Global Revenue Market Share of Prescription Weight Loss Pills by Type (2018-2029)
Figure 54. Global Prescription Weight Loss Pills Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Prescription Weight Loss Pills by Application (2018-2029)
Figure 56. Global Revenue Market Share of Prescription Weight Loss Pills by Application (2018-2029)
Figure 57. Global Prescription Weight Loss Pills Price (US$/Unit) by Application (2018-2029)
Figure 58. Prescription Weight Loss Pills Value Chain
Figure 59. Prescription Weight Loss Pills Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
